172 related articles for article (PubMed ID: 18752388)
1. Potential role of leukotriene modifiers in the treatment of chronic obstructive pulmonary disease.
Usery JB; Self TH; Muthiah MP; Finch CK
Pharmacotherapy; 2008 Sep; 28(9):1183-7. PubMed ID: 18752388
[TBL] [Abstract][Full Text] [Related]
2. Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?
Beeh KM; Beier J
Clin Exp Allergy; 2006 Feb; 36(2):142-57. PubMed ID: 16433851
[TBL] [Abstract][Full Text] [Related]
3. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications.
Tamimi A; Serdarevic D; Hanania NA
Respir Med; 2012 Mar; 106(3):319-28. PubMed ID: 22196881
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene modifiers in asthma management.
Capra V; Rovati GE
IDrugs; 2004 Jul; 7(7):659-66. PubMed ID: 15243868
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene modifiers as potential therapeutics for cardiovascular disease.
Funk CD
Nat Rev Drug Discov; 2005 Aug; 4(8):664-72. PubMed ID: 16041318
[TBL] [Abstract][Full Text] [Related]
6. Chronic obstructive pulmonary disease in a new concept.
Murărescu ED; Mitrofan EC; Mihailovici MS
Rom J Morphol Embryol; 2007; 48(3):207-14. PubMed ID: 17914487
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-9 as a possible therapeutic target in both asthma and chronic obstructive airways disease.
McNamara PS; Smyth RL
Drug News Perspect; 2005 Dec; 18(10):615-21. PubMed ID: 16491163
[TBL] [Abstract][Full Text] [Related]
8. Advances in therapy with antileukotriene drugs.
Riccioni G; Di Ilio C; Conti P; Theoharides TC; D'Orazio N
Ann Clin Lab Sci; 2004; 34(4):379-87. PubMed ID: 15648777
[TBL] [Abstract][Full Text] [Related]
9. [Leukotriene-modifiers in asthma treatment].
Gex G; Nendaz M; Janssens JP
Rev Med Suisse; 2006 Sep; 2(77):1997-8, 2000-1. PubMed ID: 17007457
[TBL] [Abstract][Full Text] [Related]
10. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Lee TA; Schumock GT; Bartle B; Pickard AS
Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
[TBL] [Abstract][Full Text] [Related]
11. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
Onoue S; Misaka S; Kawabata Y; Yamada S
Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
[TBL] [Abstract][Full Text] [Related]
12. Perspectives for cytokine antagonist therapy in COPD.
de Boer WI
Drug Discov Today; 2005 Jan; 10(2):93-106. PubMed ID: 15718158
[TBL] [Abstract][Full Text] [Related]
13. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
Chen AM; Bollmeier SG; Finnegan PM
Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
[TBL] [Abstract][Full Text] [Related]
14. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
15. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
Gordon E; Lazarus SC
J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
[TBL] [Abstract][Full Text] [Related]
16. The role of animal models in the pharmacological evaluation of emerging anti-inflammatory agents for the treatment of COPD.
Fox JC; Fitzgerald MF
Curr Opin Pharmacol; 2009 Jun; 9(3):231-42. PubMed ID: 19356979
[TBL] [Abstract][Full Text] [Related]
17. Use of inhaled anticholinergic agents in obstructive airway disease.
Restrepo RD
Respir Care; 2007 Jul; 52(7):833-51. PubMed ID: 17594728
[TBL] [Abstract][Full Text] [Related]
18. Differentiating chronic obstructive pulmonary disease from asthma.
Kuebler KK; Buchsel PC; Balkstra CR
J Am Acad Nurse Pract; 2008 Sep; 20(9):445-54. PubMed ID: 18786021
[TBL] [Abstract][Full Text] [Related]
19. [Maintenance treatment of chronic obstructive pulmonary disease].
Volla TT; Kopperud GS
Tidsskr Nor Laegeforen; 2008 Apr; 128(7):826-8. PubMed ID: 18389030
[TBL] [Abstract][Full Text] [Related]
20. Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease.
Fernandes LB; Henry PJ; Goldie RG
Ther Adv Respir Dis; 2007 Oct; 1(1):25-33. PubMed ID: 19124345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
